Shandong Ruifeng Chemical Balance Sheet Health
Financial Health criteria checks 3/6
Shandong Ruifeng Chemical has a total shareholder equity of CN¥1.1B and total debt of CN¥769.5M, which brings its debt-to-equity ratio to 67.6%. Its total assets and total liabilities are CN¥2.1B and CN¥1.0B respectively. Shandong Ruifeng Chemical's EBIT is CN¥86.9M making its interest coverage ratio 3. It has cash and short-term investments of CN¥152.6M.
Key information
67.6%
Debt to equity ratio
CN¥769.45m
Debt
Interest coverage ratio | 3x |
Cash | CN¥152.55m |
Equity | CN¥1.14b |
Total liabilities | CN¥1.00b |
Total assets | CN¥2.14b |
Recent financial health updates
No updates
Recent updates
Optimistic Investors Push Shandong Ruifeng Chemical Co., Ltd. (SZSE:300243) Shares Up 41% But Growth Is Lacking
Oct 08Shandong Ruifeng Chemical (SZSE:300243) Will Be Hoping To Turn Its Returns On Capital Around
Sep 30Shandong Ruifeng Chemical Co., Ltd.'s (SZSE:300243) 34% Share Price Plunge Could Signal Some Risk
Jun 07Shandong Ruifeng Chemical (SZSE:300243) May Have Issues Allocating Its Capital
May 24We Think That There Are Some Issues For Shandong Ruifeng Chemical (SZSE:300243) Beyond Its Promising Earnings
Apr 26Optimistic Investors Push Shandong Ruifeng Chemical Co., Ltd. (SZSE:300243) Shares Up 48% But Growth Is Lacking
Apr 23Shandong Ruifeng Chemical Co., Ltd.'s (SZSE:300243) Shares Bounce 27% But Its Business Still Trails The Market
Mar 09Financial Position Analysis
Short Term Liabilities: 300243's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥520.7M).
Long Term Liabilities: 300243's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥480.9M).
Debt to Equity History and Analysis
Debt Level: 300243's net debt to equity ratio (54.2%) is considered high.
Reducing Debt: 300243's debt to equity ratio has increased from 36.9% to 67.6% over the past 5 years.
Debt Coverage: 300243's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 300243's interest payments on its debt are well covered by EBIT (3x coverage).